Monopar Therapeutics (NASDAQ:MNPR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Monopar Therapeutics (MNPR) operate in?

Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Monopar Therapeutics Stock (NASDAQ: MNPR) stock price, news, charts, stock research, profile.

Open	$22.00
Close	-
Volume / Avg.	16.94K / 525.75K
Day Range	$21.81 - $23.00
52 Wk Range	1.55 - 38.50
Market Cap	$138.37M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	0.84%
Days to Cover	1

Recent News

3 Momentum Stocks Soaring Into 2025 and Beyond

Investors favoring a short horizon and possessing a fair amount of risk tolerance sometimes look to stocks that have already been trending upward in an effort to capitalize on their momentum. This investment strategy

MarketBeat

Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

MarketBeat Week in Review – 10/21- 10/25

Equities were mixed this week; the Dow turned lower, but the S&P and the NASDAQ finished higher. In fact, the NASDAQ hit a record high on Friday buoyed by the strong earnings report from Tesla. Overall,

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Oct 24

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$22.00
Close	-
Volume / Avg.	16.94K / 525.75K
Day Range	$21.81 - $23.00
52 Wk Range	1.55 - 38.50
Market Cap	$138.37M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	0.84%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Monopar Therapeutics (MNPR) stock?

You can purchase shares of Monopar Therapeutics (NASDAQ:MNPR) through any online brokerage.

View our list of the best stock brokerages

Who are Monopar Therapeutics (MNPR) competitors?

Other companies in Monopar Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Aligos Therapeutics (NASDAQ:ALGS), PepGen (NASDAQ:PEPG), Atossa Therapeutics (NASDAQ:ATOS) and Adaptimmune Therapeutics (NASDAQ:ADAP).

What is the forecast, or price target, for Monopar Therapeutics (MNPR) stock?

Monopar Therapeutics has a consensus price target of $21.80.

What is the current price for Monopar Therapeutics (MNPR)?

The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $22.69 last updated January 2, 2025 at 3:46 PM EST.

Does Monopar Therapeutics (MNPR) pay a dividend?

There are no upcoming dividends for Monopar Therapeutics.

When is Monopar Therapeutics (NASDAQ:MNPR) reporting earnings?

Monopar Therapeutics’s Q4 earnings are confirmed for Thursday, March 27, 2025.

Is Monopar Therapeutics (MNPR) going to split?

There is no upcoming split for Monopar Therapeutics.

What sector and industry does Monopar Therapeutics (MNPR) operate in?

Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Monopar Therapeutics

Monopar Therapeutics (MNPR) Forecast